張 鏨,林茂松
(泰州市人民醫院,江蘇 泰州 225500)
microRNAs(miRNA)是一組約22個核苷酸的長度的RNA。其可以通過序列特異性的方式,直接結合到靶基因的3’UTR(3’非翻譯區)來影響翻譯及翻譯穩定性。
Joel Pekow等人明確發現,miR-193a-3p的表達量在潰瘍性結腸炎發展為腫瘤的過程中是下降的,它通過自身表達量的減少,直接上調IL17RD,從而起到致癌作用[1]。Lin M研究表明結直腸癌患者中miR-193a-3p含量較低的患者的預后更差[2]。在食管癌細胞中mir-193a-3p表達量與化療敏感性和放射敏感性相關。mir-193a-3p可能部分通過影響PSEN1基因功能,增強放化療抵抗作用[3]。但在肝細胞癌中,mir-193a-3p的表達量是降低的[4]。
miR-193a-3p直接結合到ERBB4和S6K2基因的3’非翻譯區,抑制ERBB信號通路,達到抑癌的效果[5]。還研究發現,miR-193a-3p通過接合至KRas基因,抑制肺癌細胞的生長、增殖、轉移能力[6]。miR-193a-3p 和AEG-1應對肺癌的致癌以及轉移作用中起作用,AEG-1可能成為miR-193a-3p潛在的靶基因[7]。惡性胸膜間皮瘤是石棉誘發的癌癥,其預后較差,研究發現miR-193a-3p在該疾病中是表達量下降,是潛在的抑癌基因[8]。
miR-193a-3p通過對DNA的甲基化,抑制SRSF2,PLAU和HIC2基因,影響膀胱癌的多重耐藥性,為膀胱癌的診斷和治療提供新的思路[9]。LOXL4[10]和HOXC9[11]分別受到miR-193a-3p的直接調控抑制,提升了膀胱癌的多重耐藥性。基因ING5受到miR-193a-3p的調控,激活DNA損傷反應通路,抑制膀胱癌的多重耐藥性[12]。前列腺癌也是泌尿系統中較為常見的腫瘤之一,其預后與轉移密切相關,雄激素受體調節mirna-193a-3p直接結合到基因AJUBA上促進前列腺癌細胞的遷移,進而促進前列腺癌的轉移[13]。腎細胞癌是泌尿系最常見的腫瘤,mirna-193a-3p被發現直接結合到基因PTEN上,發揮抑制腎癌細胞的活性的作用[14]。
NLN、CCND1、PLAU、SEPN1在乳腺癌細胞中均為miR-193a-3p直接調控的靶基因。miR-193a-3p能夠通過直接結合到相關靶基因3’非翻譯區,參與抑制乳腺癌細胞的生長、遷移和侵襲能力[15]。
XIST / mir-193a-3p/RSF1軸共同參與對骨肉瘤細胞功能的調控,其可能發展和作為一個治療靶點[16]。mir-193a-3p也可以通過抑制Rab27B的表達,抑制骨肉瘤的轉移,在此過程中TGFβ、Myc/Max、ATF2/ATF3/ATF4信號通路均受到抑制[17]。
越來越多的證據表明,miRNA的異常表達在腫瘤的發生與發展中起著重要作用,miR-193a-3p在諸多惡性腫瘤中起到抑制腫瘤細胞生長的作用,涉及諸多靶點基因,其有可能成為惡性腫瘤診斷和治療的新靶點。
[1] Pekow J,et al.miR-193a-3p is a key tumor suppressor in ulcerative colitis-associated colon cancer and promotes carcinogenesis through up-regulation of IL17RD[J].clincanres.2017.
[2] Lin M,et al.Decreased expression of miR-193a-3p is associated with poor prognosis in colorectal cancer[J].Oncology Letters.2017.[3] Meng F,et al.miR-193a-3p regulation of chemoradiation resistance in oesophageal cancer cells via the PSEN1 gene[J].Gene,2016.
[4] Liu Y,et al.Down-Regulation of MiR-193a-3p Dictates Deterioration of HCC:A Clinical Real-Time qRT-PCR Study[J].Medical Science Monitor International Medical Journal of Experimental & Clinical Research,2015.
[5] Yu T,et al.MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway[J].Oncogene,2015.
[6] Seviour E G,et al.Targeting KRas-dependent tumor growth,circulating tumor cells and metastasis in vivo by clinically signi fi cant miR-193a-3p[J].Oncogene,2016.
[7] Ren F,et al.Expression and clinicopathological signi fi cance of miR-193a-3p and its potential target astrocyte elevated gene-1 in nonsmall lung cancer tissues[J].Cancer Cell International,2015.
[8] Williams M,et al.miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma[J].Oncotarget,2015.
[9] Lv L,et al.The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expression[J].Cell Death & Disease,2014.
[10] Hui D,et al.miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the Oxidative Stress pathway[J].Molecular Cancer,2014.
[11] Lv L,et al.MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene.[J].Cancer Letters,2015.
[12] Li Y,et al.The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer[J].Oncotarget,2015.
[13] Jia L,et al.Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration[J].Prostate,2017.[14] Liu L,et al.Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN.[J].Tumour Biology the Journal of the International Society for Oncodevelopmental Biology & Medicine,2017.
[15] Tsai K W,et al. Arm Selection Preference of MicroRNA-193a Varies in Breast Cancer[J].Sci Rep,2016.
[16] Pu Y,et al.MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR,respectively[J].Clinical & Experimental Metastasis,2016.
[17] Pu Y,et al.MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR,respectively[J].Clinical & Experimental Metastasis,2016.